• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $PGRE

    Paramount Group Inc.

    Subscribe to $PGRE
    $PGRE
    Real Estate Investment Trusts
    Real Estate

    Headquartered in New York City, Paramount Group, Inc. is a fully-integrated real estate investment trust that owns, operates, manages, acquires and redevelops high-quality, Class A office properties located in select central business district submarkets of New York City and San Francisco. Paramount is focused on maximizing the value of its portfolio by leveraging the sought-after locations of its assets and its proven property management capabilities to attract and retain high-quality tenants.

    IPO Year: 2014

    Exchange: NYSE

    Website: paramount-group.com

    Peers

    $AAT

    Recent Analyst Ratings for Paramount Group Inc.

    DatePrice TargetRatingAnalyst
    5/20/2025$8.00In-line → Outperform
    Evercore ISI
    4/15/2025$3.25Equal-Weight → Underweight
    Morgan Stanley
    3/18/2024$5.00Underperform → In-line
    Evercore ISI
    11/13/2023$5.00 → $4.00Neutral → Underperform
    BofA Securities
    3/1/2023$5.50Neutral
    BofA Securities
    11/23/2022$8.00 → $6.50Overweight → Equal-Weight
    Morgan Stanley
    11/21/2022$8.00 → $6.50In-line → Underperform
    Evercore ISI
    10/19/2022Buy → Neutral
    BTIG Research
    3/1/2022$10.50 → $14.00Overweight
    Morgan Stanley
    1/20/2022$11.00 → $10.50Neutral → Buy
    Mizuho
    See more ratings